Abstract
This chapter summarises the achievements of in-vivo phosphorus magnetic resonance spectroscopy (31P MRS) in the study of brain metabolism. The metabolites detectable by 31P MRS are described as also are the techniques used for spectrum analysis, signal localization and assessment of measures such as intracellular pH and magnesium. Many pathological applications of 31P MRS are also covered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ackerman JJH, Grove TH, Wong GG, Gadian DG, Radda GK (1980) Mapping of metabolites in whole animals by 31P NMR using surface coils. Nature 5743:167–170
Ackerman JJH, Evelhoch JL, Berkowitz BA, Kichura GM (1984) Selective suppression of the cranial bone resonance from 31P NMR experiments with rat brain in vivo. J Magn Reson 56:318–322
Adcock KH, Nedelcu J, Loenneker T, Martin E, Walliman T, Wagner BP (2002) Neuroprotection of creatine-supplementation in neonatal rats with transient cerebral hypoxia-ischemia. Dev Neurosci 24:383–388
Albers MJ, Krieger MD, Gonzalez-Gomez I, Gilles FH, McComb JG, Nelson MD, Bluml S (2005) Proton-decoupled 31P MRS in untreated pediatric brain tumors. Magn Reson Med 53:22–29
Allen KL, Busza AL, Proctor E, King MD, Williams SR, Crockard HA, Gadian DG (1993) Controllable graded cerebral ischaemia in the gerbil: studies of cerebral blood flow and energy metabolism by hydrogen clearance and 31P NMR spectroscopy. NMR Biomed 6:181–186
Azzopardi D, Wyatt JS, Hamilton PA, Cady EB, Delpy DT, Hope PL, Reynolds EOR (1989a) Phosphorus metabolites and intracellular pH in the brains of normal and small-for-gestational age infants investigated by magnetic resonance spectroscopy. Pediatr Res 25:440–444
Azzopardi D, Wyatt JS, Cady EB, Delpy DT, Baudin J, Stewart AL, Hope PL, Hamilton PA, Reynolds EOR (1989b) Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr Res 25:445–451
Baiden-Amissah K, Joashi U, Blumberg R, Mehmet H, Edwards AD, Cox PM (1998) Expression of amyloid precursor protein (β-APP) in the neonatal brain following hypoxic-ischaemic injury. Neuropath App Neurobiol 24:346–352
Bates TE, Williams SR, Gadian DG (1989) Phosphodiesters in the liver: the effect of field strength on the 31P signal. Magn Reson Med 12:145–150
Bischof MG, Mlynarik V, Brehm A, Bernroider E, Krssak M, Bauer E, Madl C, Bayerle-Eder M, Waldhausl W, Roden M (2004) Brain energy metabolism during hypoglycaemia in healthy and type I diabetic subjects. Diabetologia 47:648–651
Bluml S, Seymour KJ, Ross BD (1999) Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled 31P MRS in in vivo human brain. Magn Reson Med 42:643–654
Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann New York Acad Sci 508:333–348
Bottomley PA, Charles HC, Roemer PB, Flamig D, Engelseth H, Edelstein WA, Mueller OM (1988) Human in vivo phosphate metabolite imaging with 31P NMR. Magn Reson Med 7:319–336
Buchli R, Martin E, Boesiger P, Rumpel H (1994a) Developmental changes of phosphorus metabolite concentrations in the human brain: a 31P magnetic resonance spectroscopy study in vivo. Pediatr Res 35:431–435
Buchli R, Martin E, Boesiger P (1994b) Comparison of calibration strategies for the in vivo determination of absolute metabolite concentrations in the human brain by 31P MRS. NMR Biomed 7:225–230
Burri R, Lazeyras F, Aue WP, Straehl P, Bigler P, Althaus U, Herschkowitz N (1988) Correlation between 31P NMR phosphomonoester and biochemically determined phosphorylethanolamine and phosphatidylethanolamine during development of the rat brain. Dev Neurosci 10:213–221
Cady EB (1991) A reappraisal of the absolute concentrations of phosphorylated metabolites in the human neonatal cerebral cortex obtained by fitting Lorentzian curves to the 31P NMR spectrum. J Magn Reson 91:637–643
Cady EB (1995) Quantitative combined phosphorus and proton PRESS of the brains of newborn human infants. Magn Reson Med 33:557–563
Cady EB, Wilkie DR (1986) Estimation of cerebral intracellular pH by 31P and 1H nuclear magnetic resonance spectroscopy. In: Rolfe P (ed) Neonatal physiological measurements. Butterworths, London, pp 373–381
Cady EB, Wylezinska M, Penrice J, Lorek A, Amess P (1996) Quantitation of phosphorus metabolites in newborn human brain using internal water as reference standard. Magn Reson Imaging 14:293–304
Carroll RC, Edelheit EB, Schmidt PG (1980) Phosphorus nuclear magnetic resonance of bovine platelets. Biochemistry 19:3861–3867
Chapman AG, Westerberg E, Siesjo BK (1981) The metabolism of purine and pyrimidine nucleotides in rat cortex during insulin-induced hypoglycemia and recovery. J Neurochem 36:179–189
Choi I-Y, Tkac I, Gruetter R (2000) Single-shot, three-dimensional “non-echo” localization method for in vivo NMR spectroscopy. Magn Reson Med 44:387–394
Cohn M, Hughes TR (1962) Nuclear magnetic resonance spectra of adenosine di- and triphosphate. II. Effect of complexing with divalent metal ions. J Biol Chem 237:176–181
Connelly A, Counsell C, Lohman JAB, Ordidge RJ (1988) Outer volume suppressed image related in vivo spectroscopy (OSIRIS), a high-sensitivity localization technique. J Magn Reson 78:519–525
Corbett RJT, Laptook AR, Nunnally RL (1987) The use of the chemical shift of the phosphomonoester P-31 magnetic resonance peak for the determination of intracellular pH in the brains of neonates. Neurology 37:1771–1779
Corbett RJ, Laptook AR, Hassan A, Nunnally RL (1988) Quantitation of acidosis in neonatal brain tissue using the 31P NMR resonance peak of phosphoethanolamine. Magn Reson Med 6:99–106
Corbett RJT, Laptook AR (1994) Age-related changes in swine brain creatine kinase-catalyzed 31P exchange measured in vivo using 31P NMR magnetization transfer. J Cereb Blood Flow Metab 14:1070–1077
De Graff RA, Luo Y, Garwood M, Nicolay K (1996) B1-insensitive, single-shot localization and water suppression. J Magn Reson B 113:35–45
Deicken DF, Weiner MW, Fein G (1995a) Decreased temporal lobe phosphomonoesters in bipolar disorder. J Affect Disord 33:195–199
Deicken RF, Fein G, Weiner MW (1995b) Abnormal frontal lobe phosphorus metabolism in bipolar disorder. Am J Psychiatry 152:915–918
Dorsey CM, Lukas SE, Moore CM, Tartarini WL, Parow AM, Villafuerte RA, Renshaw PF (2003) Phosphorous31 magnetic resonance spectroscopy after total sleep deprivation in healthy adult men. Sleep 26:573–577
Du F, Zhu XH, Qiao H, Zhang X, Chen W (2007) Efficient in vivo 31P magnetization transfer approach for noninvasively determining multiple kinetic parameters and metabolic fluxes of ATP metabolism in the human brain. Magn Reson Med 57:103–114
Estilaei MR, Matson GB, Payne GS, Leach MO, Fein G, Meyerhoff DJ (2001a) Effects of chronic alcohol consumption on the broad phospholipid signal in human brain: an in vivo 31P MRS study. Alcohol Clin Exp Res 25:89–97
Estilaei MR, Matson GB, Payne GS, Leach MO, Fein G, Meyerhoff DJ (2001b) Effects of abstinence from alcohol on the broad phospholipid signal in human brain: an in vivo 31P magnetic resonance spectroscopy study. Alcohol Clin Exp Res 25:1213–1220
Forester BP, Berlow YA, Harper DG, Jensen JE, Lange N, Froimowitz MP, Ravichandran C, Iosifescu DV, Lukas SE, Renshaw PF, Cohen BM (2010) Age-related changes in brain energetics and phospholipid metabolism. NMR Biomed 23:242–250
Frahm J, Merboldt KD, Hanicke W (1987) Localized proton spectroscopy using stimulated echoes. J Magn Reson 72:502–508
Gabr RE, Ouwerkerk R, Bottomley PA (2006) Quantifying in vivo MR spectra with circles. J Magn Reson 179:152–163
Garlick PB, Soboll S, Bullock GR (1992) Evidence that mitochondrial phosphate is visible in 31P spectra of isolated, perfused rat hearts. NMR Biomed 5:29–36
Gee JB, Corbett RJT, Perlman J, Laptook AR (2004) The effects of systemic magnesium sulfate infusion on brain magnesium concentrations and energy state during hypoxia-ischemia in newborn miniswine. Pediatr Res 55:93–100
Gilboe DD, Kintner DB, Anderson ME, Fitzpatrick JH (1998) NMR-based identification of intra- and extracellular compartments of the brain Pi peak. J Neurochem 71:2542–2548
Glonek T, Kopp SJ, Kot E, Pettegrew JW, Harrison WH, Cohen MM (1982) P-31 nuclear magnetic resonance analysis of brain: the perchloric acid extract spectrum. J Neurochem 39:1210–1219
Glonek T, Kopp SJ (1985) Ex vivo P-31 NMR of lens, cornea, heart, and brain. Magn Reson Imaging 3:359–376
Gonen O, Mohebbi A, Stoyanova R, Brown TR (1997) In vivo phosphorus polarization transfer and decoupling from protons in three-dimensional localized nuclear magnetic resonance spectroscopy of human brain. Magn Reson Med 37:301–306
Graulich J, Hoffmann U, Maier RF, Ruscher K, Pomper JK, Ho HK, Gabriel S, Obladen M, Heinemann U (2002) Acute neuronal injury after hypoxia is influenced by the reoxygenation mode in juvenile hippocampal slice cultures. Dev Brain Res 137:35–42
Gunzel D, Schlue WR (1996) Sodium-magnesium antiport in Retzius neurones of the leech Hirudo medicinalis. J Physiol 491:595–608
Gupta RJ, Benovic JL, Rose ZB (1978) The determination of the free-magnesium level in the human red blood cell by 31P NMR. J Biol Chem 253:6172–6176
Haase A, Odoj F, von Kienlin M, Warnking J, Fidler F, Weisser A, Nittka M, Rommel E, Lanz T, Kalusche B, Griswold M (2000) NMR probeheads for in-vivo applications. Concepts Magn Reson 12:361–388
Hamakama H, Murashita J, Yamada N, Inubushi T, Kato N, Kato T (2004) Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci 58:82–88
Helpern JA, Vande Linde AM, Welch KM, Levine SR, Schultz LR, Ordidge RJ, Halvorson HR, Hugg JW (1993) Acute elevation and recovery of intracellular [Mg2+] following human focal cerebral ischemia. Neurology 43:1577–1581
Henchcliffe C, Shungu DC, Mao X, Huang C, Nirenberg MJ, Jenkins BG, Beal MF (2008) Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson’s disease. Ann NY Acad Sci 1147:206–220
Hetherington HP, Spencer DD, Vaughan JT, Pan JW (2001) Quantitative 31P spectroscopic imaging of human brain at 4 Tesla: Assessment of gray and white matter differences of phosphocreatine and ATP. Magn Reson Med 45:46–52
Hetherington HP, Pan JW, Spencer DD (2002) 1H and 31P spectroscopy and bioenergetics in the lateralization of seizures in temporal lobe epilepsy. J Magn Reson Imaging 16:477–483
Hetherington HP, Kim JH, Pan JW, Spencer DD (2004) 1H and 31P spectroscopic imaging of epilepsy: spectroscopic and histologic correlations. Epilepsia 45(suppl 4):17–23
Hida K, Kwee IL, Nakada T (1992a) T1 values of phosphomonoester and phosphocreatine of brain show no significant change during development. Magn Reson Med 27:179–182
Hida K, Kwee IL, Nakada T (1992b) In vivo 1H and 31P NMR spectroscopy of the developing rat brain. Magn Reson Med 23:31–36
Hoang TQ, Bluml S, Dubowitz DJ, Moats R, Kopyov O, Jacques D, Ross BD (1998) Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington’s and Parkinson’s diseases. Neurology 50:1033–1040
Holtzman D, Mulkern R, Tsuji M, Cook C, Meyers R (1996) Phosphocreatine and creatine kinase in piglet cerebral gray and white matter in situ. Devel Neurosci 18:535–541
Holtzman D, Mulkern R, Meyers R, Cook C, Allred E, Khait I, Jensen F, Tsuji M, Laussen P (1998) In vivo phosphocreatine and ATP in piglet cerebral gray and white matter during seizures. Brain Res 783:19–27
Hope PL, Costello AM de L, Cady EB, Delpy DT, Tofts PS, Chu A, Hamilton PA, Reynolds EOR, Wilkie DR (1984). Cerebral energy metabolism studied with phosphorus NMR spectroscopy in normal and birth-asphyxiated infants. Lancet 2: 366-370.
Hoult DI, Richards RE (1976) The signal-to-noise ratio of the nuclear magnetic resonance experiment. J Magn Reson 24:71–85
Hu MT, Taylor-Robinson SD, Chaudhuri KR, Bell JD, Labbe C, Cunningham VJ, Koepp MJ, Hammers A, Morris RG, Turjanski N, Brooks DJ (2000) Cortical dysfunction in non-demented Parkinson’s disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain 123(part 2): 340–352
Hubesch B, Sappey-Marinier D, Roth K, Meyerhoff DJ, Matson GB, Weiner MW (1990) 31P NMR spectroscopy of normal human brain and brain tumors. Radiology 174:401–409
Hugg JW, Matson GB, Twieg DB, Sappey-Marinier D, Weiner MW (1992) Phosphorus-31 MR spectroscopic imaging (MRSI) of normal and pathological human brains. Magn Reson Imaging 10:227–243
in ‘t Zandt HJ, de Groof AJ, Renema WK, Oerlemans FT, Klomp DW, Wieringa B, Heerschap A (2003) Presence of (phospho)creatine in developing and adult skeletal muscle of mice without mitochondrial and cytosolic muscle creatine kinase isoforms. J Physiol 548:847–858
in ‘t Zandt HJ, Renema WK, Streijger F, Jost C, Klomp DW, Oerlemans F, Van der Zee CE, Wieringa B, Heerschap A (2004) Cerebral creatine kinase deficiency influences metabolite levels and morphology in the mouse brain: a quantitative in vivo 1H and 31P magnetic resonance study. J Neurochem 90:1321–1330
Iwata O, Iwata S, Bainbridge A, De Vita E, Matsuishi T, Cady EB, Robertson NJ (2008) Supra- and sub-baseline PCr recovery in developing brain after transient hypoxia-ischaemia: relation to baseline energetics, insult severity and outcome. Brain 131:2220–2226
Jensen JE, Drost DJ, Menon RS, Williamson PC (2002) In vivo brain 31P-MRS: measuring the phospholipid resonances at 4 Tesla from small voxels. NMR Biomed 15:338–347
Jensen JE, Miller J, Williamson PC, Neufeld RW, Menon RS, Malla A, Manchanda R, Schaefer B, Densmore M, Drost DJ (2004) Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla. Br J Psychiatry 184:409–415
Jensen JE, Miller J, Williamson PC, Neufeld RW, Menon RS, Malla A, Manchanda R, Schaefer B, Densmore M, Drost DJ (2006) Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla. Psychiatry Res 146:127–135
Jung W-I, Widmaier S, Bunse M, Seeger U, Straubinger K, Schick F, Kuper K, Dietze G, Lutz O (1993) 31P transverse relaxation times of ATP in human brain in vivo. Magn Reson Med 30:741–743
Jung W-I, Staubert A, Widmaier S, Hoess T, Bunse M, van Erckelens F, Dietze G, Lutz O (1997) Phosphorus J-coupling constants of ATP in human brain. Magn Reson Med 37:802–804
Keshavan MS, Stanley JA, Montrose DM, Minshew NJ, Pettegrew JW (2003) Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder; an in vivo 31P MRS study. Mol Psychiatry 8:316–323
Klemm S, Rzanny R, Riehemann S, Volz HP, Schmidt B, Gerhard UC, Schonberg A, Mentzel HJ, Kaiser WA, Blanz B (2001) Cerebral phosphate metabolism in first-degree relatives of patients with schizophrenia. Am J Psychiatry 158:958–960
Kreis R, Slotboom J, Pietz J, Jung B, Boesch C (2001) Quantitation of localized 31P magnetic resonance spectra based on the reciprocity principle. J Magn Reson 149:245–250
Kuby SA, Noltmann EA (1962) ATP-creatine transphosphorylase. In: Boyer PD, Lardy H, Myrback K (eds) The enzymes, vol 6, 2nd edn. Academic, New York, pp 515–603
Lara RS, Matson GB, Hugg JW, Maudsley AA, Weiner MW (1993) Quantitation of in vivo phosphorus metabolites in human brain with magnetic resonance spectroscopic imaging (MRSI). Magn Reson Imaging 11:273–278
Le Rumeur E (1992) Saturation transfer and its application to study biochemical kinetics. In: de Certaines JD, Bovee WMMJ, Podo F (eds) Magnetic resonance spectroscopy in biology and medicine. Pergamon, Oxford, pp 169–173
Lei H, Zhu X-H, Zhang X-L, Ugurbil K, Chen W (2003a) In vivo 31P magnetic resonance spectroscopy of human brain at 7 T: an initial experience. Magn Reson Med 49:199–205
Lei H, Ugurbil K, Chen W (2003b) Measurement of unidirectional Pi to ATP flux in human visual cortex at 7 T by using in vivo 31P magnetic resonance spectroscopy. Proc Nat Acad Sci USA 100:14409–14414
Lodi R, Schapira AH, Manners D, Styles P, Wood NW, Taylor DJ, Warner TT (2000) Abnormal in vivo skeletal muscle energy metabolism in Huntington’s disease and dentatorubropallidoluysian atrophy. Ann Neurol 48:72–76
Lorek A, Takei Y, Cady EB, Wyatt JS, Penrice J, Edwards AD, Peebles D, Wylezinska M, Owen-Reece H, Kirkbride V, Cooper C, Aldridge RF, Roth SC, Brown G, Delpy DT, Reynolds EOR (1994) Delayed (“secondary”) cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res 36:99–706
Luyten PR, Bruntink G, Sloff FM, Vermeulen JWAH, van der Heijden JI, den Hollander JA, Heerschap A (1989a) Broadband proton decoupling in human 31P NMR spectroscopy. NMR Biomed 1:177–183
Luyten PR, Groen JP, Vermeulen JWAH, den Hollander JA (1989b) Experimental approaches to image localized human 31P NMR spectroscopy. Magn Reson Med 11:1–21
Madden A, Leach MO, Collins DJ, Payne GS (1991) The water resonance as an alternative pH reference: relevance to in vivo 31P NMR localized spectroscopy studies. Magn Reson Med 19:416–421
Maintz D, Heindel W, Kugel H, Jaeger R, Lackner KJ (2002) Phosphorus-31 MR spectroscopy of normal adult human brain and brain tumours. NMR Biomed 15:18–27
Martin E, Buchli R, Ritter S, Schmid R, Largo RH, Boltshauser E, Fanconi S, Duc G, Rumpel H (1996) Diagnostic and prognostic value of cerebral 31P magnetic resonance spectroscopy in neonates with perinatal asphyxia. Pediatr Res 40:749–758
Mason GF, Chu WJ, Vaughan JT, Ponder SL, Twieg DB, Adams D, Hetherington HP (1998) Evaluation of 31P metabolite differences in human cerebral gray and white matter. Magn Reson Med 39:346–353
McKnight TR (2004) Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. Semin Oncol 31:605–617
Meng S, Qiao M, Foniok T, Tuor UI (2005) White matter damage precedes that in gray matter despite similar magnetic resonance imaging changes following cerebral hypoxia-ischemia in neonatal rats. Exp Brain Res 166:56–60
Merboldt KD, Chien D, Hanicke W, Gyngell ML, Bruhn H, Frahm J (1990) Localized 31P NMR spectroscopy of the adult human brain in vivo using stimulated-echo (STEAM) sequences. J Magn Reson 89:343–361
Moon RB, Richards JH (1973) Determination of intracellular pH by 31P magnetic resonance. J Biol Chem 248:7276–7278
Mulkern RV, Greenman RL, Rybicki FJ (2003) Comments on ultrahigh field 31P ATP T2 values. Magn Reson Med 50:654–655
Murphy-Boesch J, Stoyanova R, Srinavasan R, Willard T, Vingeron D, Nelson S, Taylor JS, Brown T (1993) Proton-decoupled 31P chemical shift imaging of the human brain in normal volunteers. NMR Biomed 6:173–180
Murphy-Boesch J, Srinivasan R, Carvajal L, Brown TR (1994) Two configurations of the four-ring birdcage coil for 1H imaging and 1 decoupled 31P spectroscopy of the human head. J Magn Reson B 106:103–114
Murphy EJ, Rajagopalan B, Brindle KM, Radda GK (1989) Phospholipid bilayer contribution to 31P NMR spectra in vivo. Magn Reson Med 12:282–289
Nakada T, Kwee IL, Suzuki N, Houkin K (1989) Intrauterine fetal brain NMR spectroscopy: 1H and 31P studies in rats. Magn Reson Med 12:172–180
Nakada T, Kwee IL (1993) 31P localized spectroscopy of fetal brain in utero. Magn Reson Med 29:122–124
Oberhänsli RD, Hilton-Jones D, Bore PJ, Hands LJ, Rampling RP, Radda GK (1986) Biochemical investigation of human tumors in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet 2(8497):8–11
Ordidge RJ, Connelly A, Lohman JAB (1986) Image selected in-vivo spectroscopy (ISIS). A new technique for spatially-selected NMR spectroscopy. J Magn Reson 66:283–294
Page RA, Cady EB, Priest AN, Bainbridge A, West DA, Thornton JS, Woodman B, Bates GP, Ordidge RJ, Davie C (2003) Localised in-vivo 31P MRS in a mouse model of Huntington’s disease. In: Proceedings of the 11th Annual Meeting International Society of Magnetuc Resonance in Medicine, Toronto, Canada, p1306
Pan JW, Bebin EM, Chu WJ, Kiel S, Hetherington HP (1999) Ketosis and epilepsy: 31P spectroscopic imaging at 4.1 T. Epilepsia 40:703–708
Pearce JM, Komoroski RA (2000) Analysis of phospholipid molecular species in brain by 31P NMR spectroscopy. Magn Reson Med 44:215–223
Peeters-Scholte C, Braun K, Koster J, Kops N, Blomgren K, Buonocore G, van Buul-Offers S, Hagberg H, Nicolay K, van Bel F, Groenendaal F (2003) Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia. Pediatr Res 54:516–522
Petroff OAC, Prichard JW (1985) Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy. Neurology 35:781–788
Pettegrew JW, Kopp SJ, Dadok J, Minshew NJ, Feliksik JM, Glonek T, Cohen MM (1986) Chemical characterization of a prominent phosphomonoester resonance from mammalian brain. 31P and 1H NMR analysis at 4.7 and 14.1 Tesla. J Magn Reson 67:443–450
Pettegrew JW, Withers G, Panchalingam K, Post JFM (1988) Considerations for brain pH assessment by 31P NMR. Magn Reson Imaging 6:135–142
Pettegrew JW, Klunk WE, Panchalingam K, McClure RJ, Stanley JA (1997) Magnetic resonance spectroscopy changes in Alzheimer’s disease. Ann NY Acad Sci 826:282–306
Pettegrew JW, Panchalingam K, Hamilton RL, McClure RJ (2001) Brain membrane phospholipid alterations in Alzheimer’s disease. Neurochem Res 26:771–782
Pietz J, Rupp A, Ebinger F, Mayatepek E, Boesch C, Kreis R (2003) Cerebral energy metabolism in phenylketonuria: findings by quantitative in vivo 31P MR spectroscopy. Pediatr Res 53:654–662
Portman MA, Lassen NA, Cooper TG, Sills AM, Potchen EJ (1991) Intra- and extracellular pH of the brain in vivo studied by 31P-NMR during hyper- and hypocapnia. J Appl Physiol 71:2168–2172
Potwarka JJ, Drost DJ, Williamson PC (1999) Quantifying 1H decoupled in vivo 31P brain spectra. NMR Biomed 12:8–14
Puka-Sundvall M, Gajkowska B, Cholewinski M, Blomgren K, Lazarewicz JW, Hagberg H (2000) Subcellular distribution of calcium and ultrastructural changes after cerebral hypoxia-ischemia in immature rats. Dev Brain Res 125:31–41
Rabenstein DL, Nakashima TT (1979) Spin-echo Fourier transform nuclear magnetic resonance spectrocopy. Analyt Chem 51:1465A–1474A
Rango M, Bonifati C, Bresolin N (2006) Parkinson’s disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study. J Cereb Blood Flow Metab 26:283–290
Remy C, Albrand JP, Benabid AL, Decorps M, Jacrot M, Riondel J, Foray MF (1987) In vivo 31P nuclear magnetic resonance studies of T1 and T2 relaxation times in rat brain and in rat brain tumors implanted to nude mice. Magn Reson Med 4:144–152
Robbins RC, Balaban RS, Swain JA (1990) Intermittent hypothermic asanguineous cerebral perfusion (cerebroplegia) protects the brain during prolonged circulatory arrest. J Thorac Cardiovasc Surg 99:878–884
Robertson NJ, Cowan FM, Cox IJ, Edwards AD (2002) Brain alkaline intracellular pH after neonatal encephalopathy. Ann Neurol 52:732–742
Roth K, Hubesch B, Meyerhoff DJ, Naruse S, Gober JR, Lawry TJ, Boska MD, Matson GB, Weiner MW (1989) Noninvasive quantitation of phosphorus metabolites in human tissue by NMR spectroscopy. J Magn Reson 81:299–311
Roth K, Weiner MW (1991) Determination of cytosolic ADP and AMP concentrations and the free energy of ATP hydrolysis in human muscle and brain tissues with 31P NMR spectroscopy. Magn Reson Med 22:505–511, see erratum: 1995. Magn Reson Med 33: 282
Schuldiner S, Rozengurth E (1982) Na+/H+ antiport in Swiss 3 T3 cells: mitogenic stimulation leads to cytoplasmic alkalinization. Proc Natl Acad Sci USA 79:7778–7782
Shaka AJ, Keeler J, Freeman R (1983) Evaluation of a new broadband decoupling sequence: Waltz-16. J Magn Reson 53:313–340
Shoubridge EA, Briggs RW, Radda GK (1982) 31P NMR saturation transfer measurements of the steady state rates of creatine kinase and ATP synthetase in the rat brain. FEBS Lett 140: 288–292
Silveri MM, Pollack MH, Diaz CI, Nassar LE, Mendelson JH, Yurgelun-Todd DA, Renshaw PF, Kaufman MJ (2004) Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment. Psychiatry Res 131:217–226
Simor T, Chu WJ, Hetherington HP, Kuzniecky RI, Elgavish GA (1997) Tailored temporal lobectomy induced improvements in 4.1 T 31P NMR SI generated phosphorus metabolite indices in temporal lobe epilepsy. In: Proceedings of the 5th Annual Meeting International Society of Magnetic Resonance in Medicine, Vancouver, Canada, p 33
Skou JC (1982) The (Na+ + K+)-ATPase: coupling of the reaction with ATP to the reaction with Na + and K+. Ann N Y Acad Sci 402:169–184
Smesny S, Rosburg T, Nenadic I, Fenk KP, Kunstmann S, Rzanny R, Volz HP, Sauer H (2007) Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia. Neuroimage 35:729–737
Stubbs M, Vanstapel F, Rodrigues LM, Griffiths JR (1988) Phosphate metabolites in rat skin. NMR Biomed 1:50–55
Thoresen M, Penrice J, Lorek A, Cady EB, Wylezinska M, Kirkbride V, Cooper CE, Brown GC, Edwards AD, Wyatt JS, Reynolds EOR (1995) Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatr Res 37:667–670
Thornton JS, Ordidge RJ, Penrice J, Cady EB, Amess PN, Punwani S, Clemence M, Wyatt JS (1998) Temporal and anatomical variations of brain water apparent diffusion coefficient in perinatal cerebral hypoxic-ischemic injury: relationships to cerebral energy metabolism. Magn Reson Med 39:920–927
Thulborn KR, Ackerman JJH (1983) Absolute molar concentrations by NMR in inhomogeneous B1. A scheme for analysis of in vivo metabolites. J Magn Reson 55:357–371
Tofts PS (1988) The noninvasive measurement of absolute metabolite concentrations in vivo using surface-coil NMR spectroscopy. J Magn Reson 80:84–95
Tofts PS (1994) Standing waves in uniform water phantoms. J Magn Reson B 104:143–147
Tofts P, Wray S (1985) Changes in brain phosphorus metabolites during post-natal development of the rat. J Physiol 359:417–429
Ulrich M, Wokrina T, Ende G, Lang M, Bachert P (2007) 31P-{1 H} echo-planar spectroscopic imaging of the human brain in vivo. Magn Reson Med 57:784–790
Vanhamme L, van den Boogart A, Huffel SV (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129:35–43
Van der Knaap M, Van der Grond J, Van Rijen P, Faber J, Valk J, Willemse K (1990) Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 176:509–515
Van Sluis R, Payne GS, Leach MO (1995) Increased NOE enhancement in 1H decoupled 31P MRS. Magn Reson Med 34:893–897
Westergren I, Nystrom B, Hamberger A, Nordborg C, Johansson BB (1994) Concentrations of amino acids in extracellular fluid after opening of the blood-brain barrier by intracarotid infusion of protamine sulfate. J Neurochem 62:159–165
Wijnen JP, Scheenen TW, Klomp DW, Heerschap A (2010) 31P magnetic resonance spectroscopy imaging with polarisation transfer of phosphomono- and phosphodiesters at 3 T in the human brain: relation with age and spatial difference. NMR Biomed 23:968–976
Williams GD, Palmer C, Roberts RL, Heitjan DF, Smith MB (1992) 31P NMR spectroscopy of perinatal hypoxic-ischemic brain damage: a model to evaluate neuroprotective drugs in immature rats. NMR Biomed 5:145–153
Williams GD, Mosher TJ, Smith MB (1993) Simultaneous determination of intracellular magnesium and pH from the three 31P NMR chemical shifts of ATP. Analyt Biochem 214:458–467
Williams GD, Smith MB (1995) Application of the accurate assessment of intracellular magnesium and pH from the 31P shifts of ATP to cerebral hypoxia-ischemia in neonatal rat. Magn Reson Med 33:853–857
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Cady, E.B. (2012). In Vivo Cerebral 31P Magnetic Resonance Spectroscopy. In: Choi, IY., Gruetter, R. (eds) Neural Metabolism In Vivo. Advances in Neurobiology, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-1788-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1788-0_6
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-1787-3
Online ISBN: 978-1-4614-1788-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)